𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells

✍ Scribed by Thananya Thongtan; Nitwara Wikan; Phitchayapak Wintachai; Chutima Rattanarungsan; Chantragan Srisomsap; Poonlarp Cheepsunthorn; Duncan R. Smith


Book ID
102381010
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
208 KB
Volume
84
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Japanese encephalitis virus (JEV) a mosquito‐borne flavivirus is a major cause of viral encephalitis in Asia. While the principle target cells for JEV in the central nervous system are believed to be neurons, microglia are activated in response to JEV and have been proposed to act as a long lasting virus reservoir. Viral attachment to a host cell is the first step of the viral entry process and is a critical mediator of tissue tropism. This study sought to identify molecules associated with JEV entry to microglial cells. Virus overlay protein‐binding assay (VOPBA) and liquid chromatography–mass spectrometry (LC/MS/MS) identified the 37/67 kDa high‐affinity laminin receptor protein and nucleolin as a potential JEV‐binding proteins. These proteins were subsequently investigated for a contribution to JEV entry to mouse microglial BV‐2 cells together with other possible candidate receptor molecules including Hsp70, Hsp90, GRP78, CD14, and CD4. In antibody mediated inhibition of infection experiments, both anti‐laminin receptor and anti‐CD4 antibodies significantly reduced virus entry while anti‐Hsp70 and 90 antibodies produced a slight reduction. Significant inhibition of virus entry (up to 80%) was observed in the presence of lipopolysaccharide (LPS) which resulted in a complete down‐regulation of CD4 and moderate down‐regulation of CD14. These results suggest that multiple receptor proteins may mediate the entry of JEV to microglial cells, with CD4 playing a major role. J. Med. Virol. 84:615–623, 2012. © 2011 Wiley Periodicals, Inc.


📜 SIMILAR VOLUMES